The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2023 | Issues with CAR-T slot allocation in myeloma & the promise of locally manufactured products
In this video, Heinz Ludwig, MD, Wilhelminen Cancer Research Institute, Vienna, Austria, discusses issues regarding CAR-T slot allocation in multiple myeloma, and further comments on how academic and locally manufactured products may be used to overcome this challenge. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
